Details for Patent: 4,209,513

Summary for Patent: 4,209,513

Title:	Tablet formulation
Abstract:	A tablet suitable for use in the treatment of microbial infections, which tablet comprises from 80 to 98% (w/w) of a combination of a 2,4-diaminopyrimidine with a sulphonamide and not more than 20% (w/w) of both a granulating and a disintegrating agent, the combination having a particle size less than 40 .mu.m and the disintegrating agent having a swelling capacity greater than 5 ml/g.
Inventor(s):	Torode; Allan J. (Basildon, GB2), Harden; David (Sidcup, GB2), Spence; John (Bickley, GB2)
Assignee:	Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:	05/896,297
Patent Claim Types: see list of patent claims	Dosage form;

Drugs Protected by US Patent 4,209,513

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,209,513

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	6758/74	Feb 14, 1974

International Family Members for US Patent 4,209,513

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	344915
Austria	A108475
Australia	468465
Australia	7817075
Belgium	825496